P16 methylation
P16 gene methylation was investigated using specific primers and the protocol published by Herman et al. (Proc. Nat. Acad. Sci. USA, Vol 93, pp. 9821-9826, 1996) .
MET mRNA in situ hybridisation (ISH)
MET mRNA ISH was carried out as previously described [Cortelazzi et al., J Oral Pathol Med., Vol 44, pp. 734-45, 2015] . Briefly, 5 μm sections of formalinfixed, paraffin-embedded tissue were pre-treated, digested, and hybridised in a hybridiser (Dako Italia S.p.A., Milan, Italy) with the custom-designed MET type-1 probe (Cat. No. va1-10363-01 , QuantiGene ViewRNA, Affymetrix, Santa Clara, California, USA) in accordance with the manufacturer's instructions. Positive staining was appeared as red dots in the nucleus and/or cytoplasm. Each run also included the positive control gene peptidylprolyl isomerase B/cyclophilin B (PPIB) type-6 (Cat. No. VA-10509-01, Affymetrix) for evidence of preserved RNA.
VEGFR2 mRNA ISH
VEGFR2 mRNA ISH was carried out manually using the RNAscope kit (Advanced Cell Diagnostics, Inc., Hayward, CA) in accordance with the manufacturer's instructions. In brief, 5 μm sections of formalin-fixed, paraffin-embedded tissue were pre-treated with heat and protease before being hybridised with the Hs-VEGFR2 probe (Cat. No. 312121, Advanced Cell Diagnostics, Inc.) . A horseradish peroxidase-based signal amplification system has then bound to the target probes followed by colour development with diaminobenzidine. Positive staining appeared as brown dots in the nucleus and/or cytoplasm. The bacterial gene 4-hydroxytetrahydrodipicolinate reductase (DapB) (negative control) and the housekeeping gene ubiquitin C (UbC) (positive control) were included in each run.
miRNA ISH and quantification
MiRNA ISH was carried out as previously described [Gualeni et al, J Clin Pathol. 2015 vol 68, pp661-664 2015 . Briefly, after tissue preparation and permeabilisation, tumoral sections were hybridised for two hours with a double-DIG-LNA probe for hsa-miR-17 (Cat. No. 88084-15, Exiqon, Vedbaek, Denmark) at 61°C, an hsa-miR-21 probe (positive control; Cat. No. 38102-15, Exiqon) at 53°C, and a scramble-miR probe (negative control; Cat. No. 99004-15, Exiqon) at 57°C. Signal detection was automated using the OptiviewDAB Detection Kit (Ventana Medical Systems, Tucson, Arizona, USA) on a Ventana BenchMark ULTRA (Ventana Medical Systems). Positive miRNA 17-5p staining appeared as brown dots usually localised in the cytoplasm. The size and intensity of the dots varied from case to case.
Signals in tumour cells were quantified using a 0-9 scoring system in which the intensity of the signal (0=no signal, 1 = weak, 2 = moderate, and 3 = strong) was multiplied by the percentage of positive cells (0 = negative, 1 = <25%, 2 = 25-50%, and 3 = >50%) [Yang et al, Cancer Cell. vol ; 23, pp:186-199, 2013] . Low and high miR-17 expression levels were respectively defined as scores of <6 and ≥6.
Immunofluorescence (IF)
VEGFR2/E-cadherin, E-cadherin/P-cadherin, and E-cadherin/Gata-4 co-expression was investigated by means of IF. The antibodies were diluted as shown in Supplementary Table S2 , and the antigen retrieval was carried out using the fully automated BenchMark ULTRA (Ventana) instrument in accordance with the manufacturer's instructions. The slides were incubated with the specific secondary Alexa Fluor antibodies (Alexa Fluor 488 and Alexa Fluor 546, Thermo Fischer Scientific, MA, USA) at room temperature for one hour, and then mounted using Vectashield mounting medium with DAPI (Vector Labs, Burlingame, CA, USA). The samples were observed by means of a Leica DM6000B microscope equipped with a 100 W mercury lamp, with excitation being obtained using Spectrum Orange (546 nm), Spectrum Green (488 nm) and DAPI excitation filters. The images were acquired through 20x and 40x oil immersion objectives, and analysed using Cytovision software. The images from each channel were collected sequentially in order to limit fluorescence cross-talk. The published images represent extended depth-of-field frames in stack, with focus regions selected on the basis of their maximum intensity.
Biochemistry
The proteins from tissue samples stored at -80°C were homogenised at 4°C in lysis buffer (50 mmol/L HEPES, 150 mmol/L NaCl, 10%glycerol, 1% Triton X-100, 1.5 mmol/L MgCl 2 , 1 mmol/L EGTA, 10 mmol/L Na 4 P 2 O 7 , and 100 mmol/L NaF) supplemented with protease and phosphatase inhibitors (Cocktail Inhibitors I and II, Sigma, St. Louis, MO). The lysing involved frequent vortexing, and the lysates were then cleared by means of centrifugation at 13,000 rpm for 30 minutes at 4°C and the proteins were measured using a Bio-Rad protein assay. Western blotting (WB) was carried using standard procedures and 20 μg of proteins. The antibodies used are listed in Supplementary Table S3 .
Cell cultures
Fresh aseptic surgical MpM samples were minced and incubated with collagenase (Cat. No. C6885, Sigma) for three hours, and the obtained cell suspension was filtered through a 45 μL nylon mesh, washed with RPMI/ FCS 0.5%, diluted in PBS/BSA 1%, and seeded in RPMI (Cat. No. 21875-034, Invitrogen) supplemented with 10% of fetal bovine serum.
Biochemistry
When sub-confluence was reached, the cells were detached as described above for the surgical samples, and analysed by means of WB using the antibodies and conditions shown in Supplementary Table S3 . 4 cells were acquired using a FACS-Canto 2 cytometer, and analysed using FACS DIVA or Win MDI software.
Flow cytometry (FC)
FC
Immunoistochemistry (IHC)
The primary and stabilised cell cultures were detached using trypsin, and fixed for one hour at room temperature in a 10% solution of buffered formalin. Formalin-fixed, paraffin-embedded (FFPE) cell blocks suitable for IHC were then obtained using standard procedures. The IHC experiments were performed under the conditions shown in Supplementary Table 2.
RNA analyses
RNA was extracted from the cells using an RNeasy minikit (Cat. No. 74104, Qiagen), and quantified using nano-drop device. Five hundred nanograms of of RNA was used for RT-PCR and cDNA synthesis. cDNA retrotranscribed from 500 ng of RNA obtained from U-87 glioma cell line was used as a reference sample.
Real-time quantitative PCR
CD90, Axl, Alcam, Zeb1, CD105, c-Myc, Slug, Twist, Erb2 and beta 2 microglobulin were relatively quantified by means of real-time quantitative PCR (ABIPRISM 5700 PCR, Applied Biosystems), and the 2 -ΔΔCt method was used to calculate the relative changes in gene expression. All of the probes came from Thermofisher Scientific. CD90 (Hs 00264235_m1), Axl (Hs 1064444_m1), Alcam (Hs 00977641_m1), Zeb1 (Hs 00232783_m1), CD105 (Hs 00923996_m1), c-Myc(Hs00153408_m1), Slug (Hs 00 950344_m1), Twist (Hs 02379973_m1), Erb2 (Hs 00170433_m1) and beta 2 microglobulin (Hs00187842_m1) 
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